NCT01498926 - Comparison of Two Insulin Detemir Formulations in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

DiabetesHealthy

Interventions

DRUG

insulin detemir

Single dose containing mannitol as isotonic agent. Administered subcutaneously (s.c., under the skin)

DRUG

insulin detemir

Single dose containing glycerol as isotonic agent. Administered subcutaneously (s.c., under the skin)

Trial Locations (1)

Manchester